1st Quarter - Amendment

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$3,550,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2012 $3,540,000 Replaced
1st Quarter - Amendment (this page) May 25, 2012 $3,550,000 Yes

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —

Contacted: Executive Office of the President (EOP); State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 2280, The Offshoring Prevention Act S. 1671, The Foreign Earnings Reinvestment Act S. 1346, The Stop Tax Haven Abuse Act S. 45, The Offshoring Prevention Act S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"

LobbyistCovered position, as disclosed
KEN W COLE —
CAROLINE MOODY SCHELLHAS —

Contacted: Commerce, Dept of (DOC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1671 (112th), S. 1813 (112th), S. 1346 (112th), H.R. 2280 (112th), H.R. 2495 (112th), H.R. 2735 (112th), H.R. 1834 (112th), S. 45 (112th)

Health Issues HCR

Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
LOUIS A LAMARCA —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Bills named: S. 1734 (112th), H.R. 452 (112th), H.R. 2182 (112th), S. 668 (112th)

Animals ANI

E. coli Vaccine for Animals

LobbyistCovered position, as disclosed
MARY BRIDGET WALSH —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); SENATE; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Food & Drug Administration (FDA); Executive Office of the President (EOP); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Commerce, Dept of (DOC); SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Defense DEF

Homeland Security and Defense Issues Surrounding Readiness for a Chemical Nerve Agent Attack or Industrial Accident.

LobbyistCovered position, as disclosed
MARY BRIDGET WALSH —

Contacted: State, Dept of (DOS); Food & Drug Administration (FDA); Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO)

Alcohol and Drug Abuse ALC

Opioid Abuse Priscription Drug Abuse

LobbyistCovered position, as disclosed
JENNIFER DUCK —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Food & Drug Administration (FDA); SENATE; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Consumer Issues/Safety/Products CSP

Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Patent & Trademark Office (PTO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.